Curcumin

Curcumin

SCHEMBL25246468

CCCCC(=O)O.CCCCC(=O)O.COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 9/20 0.76
▸ MAPT P10636 7/20 0.76
▸ BACE1 P56817 4/20 0.76
▸ NFKB1 P19838 3/20 0.76
▸ MMP9 P14780 3/20 0.76
▸ ALOX5 P09917 3/20 0.76
▸ CYP2D6 P10635 2/20 0.76
▸ CYP2C9 P11712 2/20 0.76
▸ TSHR P16473 2/20 0.76
▸ HSD17B10 Q99714 2/20 0.76
▸ ABCB1 P08183 2/20 0.76
▸ AKR1B1 P15121 2/20 0.76
▸ MAOA P21397 2/20 0.76
▸ MAOB P27338 2/20 0.76
▸ HDAC3 O15379 2/20 0.76
▸ HDAC1 Q13547 2/20 0.76
▸ HDAC2 Q92769 2/20 0.76
▸ HDAC6 Q9UBN7 2/20 0.76
▸ STAT3 P40763 2/20 0.76
▸ NFKB2 Q00653 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Curcumin SCHEMBL25290658 1.00 APP (0.76) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25244302 0.96 HTR1A (0.75) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25243037 0.96 HTR1A (0.75) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25240986 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25290694 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25251023 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25247326 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25288205 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25285963 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9
Curcumin SCHEMBL25249730 0.95 HTR1A (0.73) APPMAPTBACE1NFKB1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190937-A1 IRON COMPLEXES OF ESTERIFIED DERIVATIVES OF NATURAL PRODUCTS, AND METHODS OF USE CORNELL UNIVERSITY 2023-06-22 — — US claimed
US-20230190937-A1 IRON COMPLEXES OF ESTERIFIED DERIVATIVES OF NATURAL PRODUCTS, AND METHODS OF USE CORNELL UNIVERSITY 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190937-A1 IRON COMPLEXES OF ESTERIFIED DERIVATIVES OF NATURAL PRODUCTS, AND METHODS OF USE SLC40A1, TFRC, HAMP APP 2733/4885MAPT 3778/4885BACE1 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback